An 18-year-old man with metastatic femoral osteosarcoma had inadequate pain control with gabapentin, naproxen and intravenous fentanyl. A tunnelled femoral nerve catheter was used to administer a continuous infusion of 0.2% ropivacaine and 4 µg/ml clonidine (10 ml/hour) until his death 88 days later. During discharge from hospital, catheter disconnection resulted in severe pain and readmission. Tunnelling, aseptic insertion technique, antibiotics and sterile infusate prepared by the pharmacy may have reduced the chance of infection. We propose that this is a suitable and effective technique in the long-term management of patients with terminal cancer and should be considered on a case-by-case basis.
Continuous peripheral nerve blocks (CPNB) are often used to provide postoperative analgesia, during which catheters typically remain in situ for two to seven days 1 . In some cases, CPNBs have been used in palliative care for up to six weeks 2 . We report the case of an 18-year-old with terminal cancer for whom a continuous tunnelled femoral nerve block provided adequate pain relief for 88 days.
CASE HISTORY
Patient consent was given prior to presenting the following information. An 18-year-old African-American male weighing 71 kg was diagnosed with osteosarcoma of the left distal femur with a pathological fracture and bilateral pulmonary metastases. He received a course of chemotherapy but declined palliative above-knee amputation.
Four months before his death, he began to experience breakthrough pain despite oral and transdermal opioids, gabapentin and naproxen. Intravenous patient-controlled analgesia fentanyl was commenced, but pain control remained inadequate.
A tunnelled left femoral nerve catheter for a CPNB was inserted under general anaesthesia. The procedure was performed with a strict aseptic technique, using a cap, face-mask, sterile gloves and sterile gown. The nerve was identified by ultrasound and then localised with a stimulating needle. Patellar snap was elicited at 0.7 mA. A catheter (Stimuplex ® , B. Braun, Melsungen, Germany) was then threaded along the nerve sheath. After a negative aspiration of blood, an initial bolus of 0.5% bupivacaine (10 ml) was injected in increments of 2 ml. A 9 cm, 18 gauge Tuohy needle was used to tunnel the catheter. The stylet of the needle was inserted at the exact point of entry of the catheter and tunnelled subcutaneously to a convenient point approximately 6 cm laterally. At the exit point of the stylet, the needle was fed back (over the stylet as a guide) to emerge at the site of the catheter insertion. The catheter was then fed through the needle until it exited from the proximal end of the Tuohy needle. Finally, the needle was removed and the catheter remained in its tunnelled position. No procedural complications were encountered.
A continuous infusion of 0.2% ropivacaine and 4 µg/ml clonidine ( (12 hours/day) was also applied to treat persistent posterior thigh pain. The patient's pain scores decreased markedly
The patient was briefly discharged with the femoral catheter 58 days after insertion but returned the following day with excruciating pain after the catheter had become accidentally disconnected from the 'snap-lock' 10 hours previously. The catheter was cleaned with alcohol and connected to a fresh snap-lock. He was given 20 ml of 3% chloroprocaine and 20 ml of 0.2% ropivacaine and his pain decreased markedly over the next 15 minutes. He was readmitted and a fresh infusion set was connected and restarted. He remained an inpatient for social reasons until his death.
Management that may have been relevant to the femoral catheter included the administration of sulfamethoxazole/trimethoprim three times a week before and after catheter insertion and catheter dressing changes three times a week. Solutions for infusion were prepared in the pharmacy, using a sterile technique, and changed at least every 96 hours.
Additional end-of-life care consisted of intravenous patient-controlled analgesia hydromorphone (average at time of death 14.2 mg/hour), a 5% lignocaine patch (posterior thigh), ketorolac 30 mg intravenously every eight hours and gabapentin 800 mg b.d. Although the tumour was very large in the last month of his life (Figure 1) , the patient died comfortably with minimal pain. His femoral nerve block had remained in place for 88 days.
DISCUSSION
The tunnelled catheter for continuous femoral nerve block provided adequate pain control for 88 days for our immunocompromised patient, and he showed no signs of infection. Although his mobility was extremely limited because of the large size of the tumour and pathological fracture, the nerve block was helpful in controlling his pain both while he was immobile and when he was moving for dressing changes.
CPNBs have been extensively used postoperatively as they provide good-quality analgesia with few sideeffects 1 . Studies on the use of CPNBs for palliative care are fewer than those on postoperative analgesia, however 10% of patients with advanced-stage cancer have unmanageable pain despite the use of opioids. The procedure is especially useful in patients for whom escalating doses of opioids or unacceptable side-effects limit the ability to control pain 2 .
Catheters are typically left in place for two to seven days for postoperative analgesia 1 , however infusions via catheters in the sacral root and brachial plexus have been used for up to 42 days for chronic pain 2,3 and the longest reported use of a femoral nerve block was 45 days 4 . In our patient, the nerve block was continuously infused for 88 days.
For all interventional procedures, the risks must be considered. When our patient was discharged with the femoral block in situ, the catheter was accidentally disconnected from the pump. Such technical complications are the most common adverse event in studies of CPNBs 1,5 but are usually resolved quickly without affecting patient care 1 . A technical complication may become clinically significant if there is a delay in recognising the problem and transporting the patient back to the hospital 5 . Despite this risk, CPNBs can be effective in an outpatient setting if the family is educated about the nerve block and pump and the medical team is available for follow-up assessment 5 .
An important concern with the extended use of peripheral nerve blocks is infection, as studies have found a correlation between the duration of catheter use and the risk of inflammation and infection 1, 6 . Catheter infections may result in serious complications such as cellulitis and, for femoral blocks, a psoas abscess 1, 7, 8 . One protective practice is the use of antibiotic prophylaxis, as studies have shown that the risk of infection and inflammation increases if prophylactic antibiotics are not used 1,9 . At the time of catheter insertion, our patient was taking trimethoprim/sulfamethoxazole. Another factor is the manner in which the solution is prepared and the 'hang-time' of each infusion bag, as non-sterile infusates have been implicated in the development of nerve catheter-related infections 8 . For our patient, the hospital pharmacy prepared the solution in compliance with US Pharmacopeia's Revised General Chapter <797> Pharmaceutical Compounding -Sterile Preparations, and each bag was hung for a maximum of 96 hours.
Subcutaneous tunnelling of the catheter may help reduce the risk of catheter infection, as infections from nerve blocks are usually thought to arise from bacteria on the skin at the catheter insertion site 1, 6, 7 . The goal of subcutaneous tunnelling is to increase the distance between the insertion site and the nerve that is blocked 10 . Studies of critically ill patients have shown a significant reduction in central venous catheter-related sepsis when tunnelling was used 11 and the mechanism for CPNB sepsis is believed to be similar 10 .
Compere et al 10 recently evaluated the effect of subcutaneous tunnelling in 402 patients receiving nerve blocks for 48 hours postoperatively. A catheter colonisation rate of only 6.2% 10 was found, which is much lower than rates of 17 to 57% reported in studies that did not use tunnelling 1, 9, 12 . In the same study, in which all catheters were tunnelled, no correlation was found between extended duration of catheter use and increased risk of inflammation and infection 10 . This contrasts with studies of nontunnelled catheters in which increased duration of catheter usage has been found to be associated with increased risk of inflammation and infection 1, 6 .
In addition to the decreased risk of infection, tunnelling also secures the placement of the catheter, thus decreasing the risk of catheter dislodgement 13, 14 . It is a simple technique, that is easy to learn and uses equipment that is readily available and familiar to all anaesthesia providers.
Although the risks must be considered, in our patient the potential benefits outweighed the possibility of complications. The lack of any serious infectious complication may be attributed to subcutaneous tunnelling, prophylactic antibiotics and infusate preparation under sterile conditions. We propose that continuous tunnelled peripheral nerve block is an effective technique for the management of patients with terminal cancer.
